Post Kala-azar Dermal Leishmaniasis (PKDL) is a chronic but not life-threatening disease; patients generally do not demand treatment, deserve much more attention because PKDL is highly relevant in the context of Visceral Leishmaniasis (VL) elimination. There is no stan-dard guideline for diagnosis and treatment for PKDL. A species-specific PCR on slit skin smear demonstrated a sensitivity of 93.8%, but it has not been applied for routine diagnostic purpose. The study was conducted to determine the actual disease burden in an endemic area of Malda district, West Bengal, comparison of the three diagnostic tools for PKDL case detection and pattern of lesion regression after treatment. The prevalence of PKDL was determined by active surveillanc...
Background: Visceral leishmaniasis, also known on the Indian subcontinent as kala-azar, is a fatal f...
Background: Leishmaniasis manifests as visceral (VL), cutaneous (CL) or a dermal sequel of VL, known...
BACKGROUND: On the Indian subcontinent, visceral leishmaniasis (VL) incidence is on track to reach e...
kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrosp...
Copyright © 2015 Neena Verma et al. This is an open access article distributed under the Creative Co...
Leishmaniasis is one of the most important vector borne diseases caused by kinetoplastid protozoa Le...
Visceral leishmaniasis, commonly known as kala-azar, is a systemic disease caused by parasitic proto...
More than 20 million peopl in Bangladesh are considered at risk of developing visceral leishmaniasis...
BACKGROUND: As Bangladesh, India and Nepal progress towards visceral leishmaniasis (VL) elimination,...
BACKGROUND: As Bangladesh, India and Nepal progress towards visceral leishmaniasis (VL) elimination,...
To support the Bangladesh National Kala-azar Elimination Programme (NKEP), we investigated the feasi...
Visceral Leishmaniasis (VL) is a neglected tropical disease that afflicts some of the poorest popula...
Background: Leishmaniasis is a group of diseases that are created by intracellular parasites of Leis...
Background: Cutaneous leishmaniasis is an annoying and disfiguring disease affecting around 1,500,00...
Background The contribution of individuals with subclinical infection to the transmission and endemi...
Background: Visceral leishmaniasis, also known on the Indian subcontinent as kala-azar, is a fatal f...
Background: Leishmaniasis manifests as visceral (VL), cutaneous (CL) or a dermal sequel of VL, known...
BACKGROUND: On the Indian subcontinent, visceral leishmaniasis (VL) incidence is on track to reach e...
kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrosp...
Copyright © 2015 Neena Verma et al. This is an open access article distributed under the Creative Co...
Leishmaniasis is one of the most important vector borne diseases caused by kinetoplastid protozoa Le...
Visceral leishmaniasis, commonly known as kala-azar, is a systemic disease caused by parasitic proto...
More than 20 million peopl in Bangladesh are considered at risk of developing visceral leishmaniasis...
BACKGROUND: As Bangladesh, India and Nepal progress towards visceral leishmaniasis (VL) elimination,...
BACKGROUND: As Bangladesh, India and Nepal progress towards visceral leishmaniasis (VL) elimination,...
To support the Bangladesh National Kala-azar Elimination Programme (NKEP), we investigated the feasi...
Visceral Leishmaniasis (VL) is a neglected tropical disease that afflicts some of the poorest popula...
Background: Leishmaniasis is a group of diseases that are created by intracellular parasites of Leis...
Background: Cutaneous leishmaniasis is an annoying and disfiguring disease affecting around 1,500,00...
Background The contribution of individuals with subclinical infection to the transmission and endemi...
Background: Visceral leishmaniasis, also known on the Indian subcontinent as kala-azar, is a fatal f...
Background: Leishmaniasis manifests as visceral (VL), cutaneous (CL) or a dermal sequel of VL, known...
BACKGROUND: On the Indian subcontinent, visceral leishmaniasis (VL) incidence is on track to reach e...